These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16146636)

  • 21. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
    Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
    Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.
    Xi G; Maile LA; Yoo SE; Clemmons DR
    J Cell Physiol; 2008 Feb; 214(2):306-15. PubMed ID: 17607710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis.
    Baughn LB; Rosenberg N
    J Virol; 2005 Feb; 79(4):2325-34. PubMed ID: 15681433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
    Rojas M; Yao S; Donahue JP; Lin YZ
    Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase.
    Jones N; Hardy WR; Friese MB; Jorgensen C; Smith MJ; Woody NM; Burden SJ; Pawson T
    Mol Cell Biol; 2007 Jul; 27(13):4759-73. PubMed ID: 17452444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation and selectivity of the two Grb2 binding sites of p52Shc in T-cell antigen receptor signaling to Ras family GTPases and Myc-dependent survival.
    Patrussi L; Savino MT; Pellegrini M; Paccani SR; Migliaccio E; Plyte S; Lanfrancone L; Pelicci PG; Baldari CT
    Oncogene; 2005 Mar; 24(13):2218-28. PubMed ID: 15688026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.
    Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ
    Mol Cell Biol; 1999 Dec; 19(12):8169-79. PubMed ID: 10567542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
    Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
    J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen-homology domain 1 deletion mutant of Shc suppresses transformation mediated by neu through a MAPK-independent pathway.
    Li K; Shao R; Hung MC
    Oncogene; 1999 Apr; 18(16):2617-26. PubMed ID: 10353605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells.
    Das R; Vonderhaar BK
    Oncogene; 1996 Sep; 13(6):1139-45. PubMed ID: 8808687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of mitogenic effect of fluoride on fetal rat osteoblastic cells: evidence for Shc, Grb2 and P-CREB-dependent pathways.
    Chae HJ; Chae SW; Kang JS; Kim DE; Kim HR
    Res Commun Mol Pathol Pharmacol; 1999; 105(3):185-99. PubMed ID: 10954125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
    Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
    J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.
    Rozakis-Adcock M; McGlade J; Mbamalu G; Pelicci G; Daly R; Li W; Batzer A; Thomas S; Brugge J; Pelicci PG; Schlessinger J; Pawson T
    Nature; 1992 Dec; 360(6405):689-92. PubMed ID: 1465135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
    Lee MS; Igawa T; Lin MF
    Oncogene; 2004 Apr; 23(17):3048-58. PubMed ID: 14990987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
    Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
    J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.
    Mainiero F; Murgia C; Wary KK; Curatola AM; Pepe A; Blumemberg M; Westwick JK; Der CJ; Giancotti FG
    EMBO J; 1997 May; 16(9):2365-75. PubMed ID: 9171350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 5 signals through Shc and Grb2 in human eosinophils.
    Bates ME; Busse WW; Bertics PJ
    Am J Respir Cell Mol Biol; 1998 Jan; 18(1):75-83. PubMed ID: 9448048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.